Evidence map›Paper›PMID 33440823›Full record

ArticleDiagnostics (Basel, Switzerland)2021

The Route to Autism Spectrum Diagnosis in Pediatric Practice in Bulgaria.

Ivan Ivanov, Iliyana Pacheva, Elena Timova, Ralitsa Iordanova, Fani Galabova, Katerina Gaberova, Aneliya Petkova, Vasil Kotetarov, Margarita Panova, Nikolay Tonchev and 1 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Ivan IvanovDepartment of Pediatrics and Medical Genetics, University Hospital "St. George", 4000 Plovdiv, Bulgaria.
Iliyana PachevaDepartment of Pediatrics and Medical Genetics, University Hospital "St. George", 4000 Plovdiv, Bulgaria.ORCID 0000-0003-0461-9065
Elena TimovaDepartment of Pediatrics and Medical Genetics, University Hospital "St. George", 4000 Plovdiv, Bulgaria.
Ralitsa IordanovaDepartment of Pediatrics and Medical Genetics, University Hospital "St. George", 4000 Plovdiv, Bulgaria.
Fani GalabovaDepartment of Pediatrics and Medical Genetics, University Hospital "St. George", 4000 Plovdiv, Bulgaria.
Katerina GaberovaDepartment of Pediatrics and Medical Genetics, University Hospital "St. George", 4000 Plovdiv, Bulgaria.
Aneliya PetkovaDepartment of Pediatrics and Medical Genetics, University Hospital "St. George", 4000 Plovdiv, Bulgaria.
Vasil KotetarovDepartment of Pediatrics and Medical Genetics, Medical Faculty, Medical University, 4000 Plovdiv, Bulgaria.
Margarita PanovaDepartment of Pediatrics and Medical Genetics, University Hospital "St. George", 4000 Plovdiv, Bulgaria.
Nikolay TonchevUnique Medical Center, 4000 Plovdiv, Bulgaria.
Lauren FranzDuke Center for Autism and Brain Development, Deptment of Psychiatry, Durham, NC 27705, USA.
Medical University Plovdiv · BGCenter for Autism and Related Disorders · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosis of autism spectrum disorder (ASD) before the age of three years is a challenge. Analyzing the present practice may help reaching that goal.

aimTo investigate developmental abnormalities and diagnostic pathway of ASD patients in pediatric practice.

methodsRetrospective cross-sectional study of 192 children aged 13 months to 17 years 11 months (average 4 years 9 months), investigated in an outpatient and hospital setting from January 2015 to June 2018 by a semi-structured history and clinical examination, and diagnosed with ASD by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.

resultsBehavioral peculiarities were detected in the history of the first two years of life in 74.8% of the subjects. The first developmental abnormalities were noticed by the parents at ages from 8 to 36 months (mean 15.6 months) and were predominantly in speech (in 94.6%) and non-verbal communication (11.3%). Developmental regression was reported in 42.1% of the patients occurring between the ages of 6 and 50 months (mean 17.9 months), affecting most commonly speech (88.4% of cases), non-verbal communication (29.2%), and behavior (12.8%). By history, the first manifestations of ASD were noticed at ages from 8 months to 84 months (mean 18.5 months), and were disorders of expressive speech (in 66.7% of cases), receptive speech (in 45.8%), non-verbal communication (35.4%), behavior (27.6%), play (8.9%), socialization (5.7%), and joint attention (2.1%). The most common motive for specialized consultation was delay in language development-in 84.6% of children. The age of ASD diagnosis varied between 12 and 132 months (mean 39.7 months), and the time period between first ASD manifestations and diagnosis was in the range of 0 to 79 months (mean 23.3 months). Many symptoms of abnormal social communication, unnoticed by parents, were detected objectively in more than 95% of the cases-absent or rare spontaneous or reciprocal smile; lack of sharing of interest or affect; abnormal eye contact; lack of finger pointing; lack of gaze to a pointed object; poor facial expressions; lack of imaginary play, etc. Conclusions: Almost two years are needed for diagnosing abnormal development in other domains besides speech in ASD patients. Diagnosis before the age of three years can be achieved by focusing parents' and pediatricians' attention on social communication and behavior in patients with speech delay or developmental regression.

Indexed as

age of diagnosisautismneurodevelopmentpediatrics

Identifiers

PMID33440823
PMCPMC7827839
OpenAlexW3119534799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.